Developer docs
API playgroundTry for free, no card

Search company profiles

Towards Healthcare

Full company profile

uuid00qm8b6

Namestring
Towards Healthcare
Legal namestring
Towards Healthcare Research & Consulting
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Towards Healthcare Research & Consulting is a privately held healthcare market research and consulting firm headquartered in Pune, Maharashtra, India, with a secondary office in Ottawa, Canada. The company operates a vertically specialized healthcare intelligence platform serving pharmaceutical and biotechnology companies, management consulting firms (McKinsey, BCG, Bain, Deloitte, PwC, KPMG), medical device manufacturers (Stryker, BD), life sciences companies (Danaher, Thermo Fisher), healthcare investors, and policymakers across more than 50 countries. Its product portfolio centers on the Healthcare Intelligence Platform and the Cell & Gene Therapy Intelligence Platform, which provide real-time data on market sizing, pipeline programs, patient populations, and regulatory environments. Supporting offerings include syndicated and custom market research reports, Market Databooks, Company Profiles with SWOT analysis, Segmental Analysis, and Market Share Analysis modules covering biotechnology, diagnostics, healthcare services, medical imaging, therapeutics, laboratory equipment, medical devices, and healthcare IT.

The firm's revenue model combines recurring annual subscriptions (USD 495/month billed annually), one-time report licensing (single region starting at USD 3,800, corporate licenses available upon request), credit-based press release publishing services ($200 per release or bundled credits), and custom research and consulting engagements. Go-to-market is dual-motion: a self-serve digital storefront for individual report purchases and subscriptions, supplemented by a direct sales team with regional phone coverage in the USA, APAC, and Europe, and a dedicated APAC-focused sales executive. Marketing channels span SEO-optimized content, LinkedIn and Twitter presence, email newsletters, press releases, client testimonials, and industry events. The team includes approximately ten named professionals covering research, consulting, content, sales, and digital marketing functions, with affiliations to sister platforms Precedence Research and Statifacts. No funding rounds, M&A activity, or public financial disclosures are documented, and revenue figures are not publicly disclosed.

Short descriptiontext

Towards Healthcare is a privately held Pune-based healthcare market research and consulting firm offering syndicated reports, custom research, and intelligence platforms to pharmaceutical, biotech, medical device, and consulting clients across 50+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersPune, India
HQ citystring
Pune
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
healthcare market research, syndicated research reports, market intelligence platform, competitive intelligence services, custom research consulting
Industry1 code
1Industry & Sector Research (Syndicated/Custom)
CodeBPAHALAEPrimaryYes
NAICS code2 codes
  • Other Scientific and Technical Consulting Services54169
  • Other Management Consulting Services541618
SIC code1 code
  • Services-Management Consulting Services8742
Product category
Healthcare Market Research & Intelligence
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Annual Subscription Membership
TypeSubscription Recurring
Description

Subscription-based revenue model offering annual membership at USD 495 per month (billed annually). Provides exclusive access to in-house production platform, support team for inquiries and custom research requests, customizable reports for members including in-depth analysis and key market metrics, global market trend insights, and regional market specifics analysis.

towardshealthcare.com
2Market Research Reports (One-time Purchase)
TypeOne Time License
Description

Individual market research reports sold as one-time licenses with multiple pricing tiers: Single Region (USD 3,800), Multi-region options, and Corporate licenses. Reports include PDF, PPT, and Excel formats. Additional pricing: Databook (USD 2,700), Competitive Intelligence (USD 7,400), Cross-Sectional Analysis (USD 4,500).

towardshealthcare.com
3Press Release Services
TypeTransaction Fee
Description

Press release publishing services with pay-per-use model ($200 per release) and credit packages (10 credits for $1,880, 25 credits for $4,600, 50 credits for $9,000). Credits valid for 6 months.

towardshealthcare.com
4Custom Research and Consulting
TypeProfessional Services
Description

Customized research services and consulting engagements. Delivery within 2-48 hours for standard reports, 4-5 working days for printed reports. Additional customization delivered per analyst timelines.

towardshealthcare.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details7 tiers
1Annual Membership - USD 495/Month
ModelSubscriptionBilling cadenceAnnual
Notes

USD 495 per month billed annually. Includes exclusive platform access, support team assistance, customizable reports with in-depth analysis, global trend insights, and regional market analysis.

towardshealthcare.com
2Single User License
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Single region license starting at USD 3,800 for market research reports. Includes PDF, PPT, Excel formats.

towardshealthcare.com
3Corporate License
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

Corporate license pricing available upon request. Includes comprehensive market analysis with competitive intelligence and cross-sectional analysis (USD 9,400).

towardshealthcare.com
4Pay Per Use - USD 200 per release
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$200 per press release. No commitment required. Credits valid for 6 months for multi-credit packages.

towardshealthcare.com
510 Credits - USD 1,880 (Save 6%)
ModelUnit PricingBilling cadenceMulti-year contract
Notes

$1,880 for 10 press release credits. 6% savings compared to pay-per-use. Valid for 6 months.

towardshealthcare.com
625 Credits - USD 4,600 (Save 8%)
ModelUnit PricingBilling cadenceMulti-year contract
Notes

$4,600 for 25 press release credits. 8% savings compared to pay-per-use. Valid for 6 months.

towardshealthcare.com
750 Credits - USD 9,000 (Save 10%)
ModelUnit PricingBilling cadenceMulti-year contract
Notes

$9,000 for 50 press release credits. 10% savings compared to pay-per-use. Valid for 6 months.

towardshealthcare.com
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Cell & Gene Therapy Intelligence Platform
Description

Real-time intelligence platform for global cell and gene therapy industry, providing data on market size, patient populations, pipeline programs, and manufacturing facilities.

towardshealthcare.com
Core offering1 text field

Towards Healthcare Research & Consulting is a healthcare-focused market research firm that sells syndicated market research reports, custom research and consulting engagements, and subscription-based access to specialized healthcare intelligence platforms covering biotechnology, diagnostics, medical devices, healthcare IT, therapeutic areas, and cell and gene therapy. It also publishes press releases on behalf of clients and offers market databooks, company profiles, segmental analysis, and market share analysis as integrated research deliverables.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Serves 1,200+ active clients globally across 50+ countries
+2 more records
Product overview1 text field

Towards Healthcare operates as a comprehensive healthcare market research platform offering multiple integrated products and services. The core offering includes the Healthcare Intelligence Platform and Cell & Gene Therapy Intelligence Platform, supplemented by syndicated and custom market research reports. Additional modules include Market Databook, Company Profiles, Segmental Analysis, and Market Share Analysis services. The platform provides subscription-based access to research reports, analytics, and strategic insights across healthcare segments including biotechnology, diagnostics, medical devices, healthcare IT, and therapeutic areas.

Product and service1 record
1Healthcare Intelligence Platform
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Long-standing provider of syndicated market research, custom consulting, and Growth Partnership subscriptions across healthcare and other verticals. Directly overlaps with Towards Healthcare's subscription + custom research revenue model.

TypeDirect peer
Description

Specialized market research provider focused on advanced therapeutics, including cell and gene therapy. Direct competitor to Towards Healthcare's specialized CGT Intelligence Platform and adjacent syndicated offerings.

TypeDirect peer
Description

Syndicated market research publisher with strong healthcare coverage and similar report-based, license-tier pricing. Competes head-to-head for mid-market enterprise healthcare research buyers.

TypeDirect peer
Description

Large-scale syndicated and custom research provider with deep healthcare and life sciences coverage. Direct competitor to Towards Healthcare's syndicated intelligence and Company Profiles offerings, but at significantly larger scale.

TypeDirect peer
Description

India-headquartered market research firm selling syndicated reports and consulting across healthcare and other industries. Closely comparable to Towards Healthcare in size, pricing model, and digital self-serve distribution.

TypeDirect peer
Description

Healthcare-focused market research firm with syndicated reports and consulting services. Competes on similar pricing tiers, digital self-serve model, and pharmaceutical/biotech customer base.

TypeDirect peer
Description

Healthcare-focused market research and consulting firm covering pharma, biotech, and emerging therapies. Direct competitor in the same customer base (Roche, AbbVie, Merck, etc.) and overlapping cell & gene therapy and pipeline intelligence.

TypeBroad incumbent
Description

Global leader in healthcare intelligence, clinical research, and commercial analytics. Competes with Towards Healthcare for enterprise pharma and biotech market intelligence budgets, but with vastly deeper data assets and an integrated services stack.

TypeDirect peer
Description

Syndicated research publisher with broad healthcare, biotech, and medical device coverage. Competes on similar report pricing, digital distribution, and global enterprise buyer targets.

TypeEmerging player
Description

Affiliated research platform sharing team members with Towards Healthcare; provides syndicated market research across healthcare and other industries. Closely related entity rather than a pure competitor, but shares IP and analyst resources.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers17 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Towards Healthcare

Healthcare Market Research & Intelligencetowardshealthcare.com

Towards Healthcare is a privately held Pune-based healthcare market research and consulting firm offering syndicated reports, custom research, and intelligence platforms to pharmaceutical, biotech, medical device, and consulting clients across 50+ countries.

What Towards Healthcare does

Towards Healthcare Research & Consulting is a privately held healthcare market research and consulting firm headquartered in Pune, Maharashtra, India, with a secondary office in Ottawa, Canada. The company operates a vertically specialized healthcare intelligence platform serving pharmaceutical and biotechnology companies, management consulting firms (McKinsey, BCG, Bain, Deloitte, PwC, KPMG), medical device manufacturers (Stryker, BD), life sciences companies (Danaher, Thermo Fisher), healthcare investors, and policymakers across more than 50 countries. Its product portfolio centers on the Healthcare Intelligence Platform and the Cell & Gene Therapy Intelligence Platform, which provide real-time data on market sizing, pipeline programs, patient populations, and regulatory environments. Supporting offerings include syndicated and custom market research reports, Market Databooks, Company Profiles with SWOT analysis, Segmental Analysis, and Market Share Analysis modules covering biotechnology, diagnostics, healthcare services, medical imaging, therapeutics, laboratory equipment, medical devices, and healthcare IT.

The firm's revenue model combines recurring annual subscriptions (USD 495/month billed annually), one-time report licensing (single region starting at USD 3,800, corporate licenses available upon request), credit-based press release publishing services ($200 per release or bundled credits), and custom research and consulting engagements. Go-to-market is dual-motion: a self-serve digital storefront for individual report purchases and subscriptions, supplemented by a direct sales team with regional phone coverage in the USA, APAC, and Europe, and a dedicated APAC-focused sales executive. Marketing channels span SEO-optimized content, LinkedIn and Twitter presence, email newsletters, press releases, client testimonials, and industry events. The team includes approximately ten named professionals covering research, consulting, content, sales, and digital marketing functions, with affiliations to sister platforms Precedence Research and Statifacts. No funding rounds, M&A activity, or public financial disclosures are documented, and revenue figures are not publicly disclosed.

Towards Healthcare firmographics

Firmographics
Name
Towards Healthcare
Legal name
Towards Healthcare Research & Consulting
Website
https://towardshealthcare.com
Company type
Private
Operating status
Operating
Headcount range
51–100 employees
Short description
Towards Healthcare is a privately held Pune-based healthcare market research and consulting firm offering syndicated reports, custom research, and intelligence platforms to pharmaceutical, biotech, medical device, and consulting clients across 50+ countries.
Ownership category
akta.pro rank

Towards Healthcare industry classification

Industry
Product category
Healthcare Market Research & Intelligence
NAICS
Other Scientific and Technical Consulting Services (54169), Other Management Consulting Services (541618)
SIC
Services-Management Consulting Services (8742)
akta.pro primary industry
Industry & Sector Research (Syndicated/Custom) (BPAHALAE)

Keywords

  • Healthcare market research
  • Syndicated research reports
  • Market intelligence platform
  • Competitive intelligence services
  • Custom research consulting

Where Towards Healthcare is headquartered

Location

Headquarters

HQ city
Pune
HQ country
India
HQ region
Asia

Offices2 records

Markets served

Towards Healthcare business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Annual Subscription Membership: Subscription-based revenue model offering annual membership at USD 495 per month (billed annually). Provides exclusive access to in-house production platform, support team for inquiries and custom research requests, customizable reports for members including in-depth analysis and key market metrics, global market trend insights, and regional market specifics analysis.
  2. Market Research Reports (One-time Purchase): Individual market research reports sold as one-time licenses with multiple pricing tiers: Single Region (USD 3,800), Multi-region options, and Corporate licenses. Reports include PDF, PPT, and Excel formats. Additional pricing: Databook (USD 2,700), Competitive Intelligence (USD 7,400), Cross-Sectional Analysis (USD 4,500).
  3. Press Release Services: Press release publishing services with pay-per-use model ($200 per release) and credit packages (10 credits for $1,880, 25 credits for $4,600, 50 credits for $9,000). Credits valid for 6 months.
  4. Custom Research and Consulting: Customized research services and consulting engagements. Delivery within 2-48 hours for standard reports, 4-5 working days for printed reports. Additional customization delivered per analyst timelines.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualAnnual Membership - USD 495/Month
One time/ perpetual licensePay-as-you-goSingle User License
One time/ perpetual licensePay-as-you-goCorporate License
Unit PricingPay-as-you-goPay Per Use - USD 200 per release
Unit PricingMulti-year contract10 Credits - USD 1,880 (Save 6%)
Unit PricingMulti-year contract25 Credits - USD 4,600 (Save 8%)
Unit PricingMulti-year contract50 Credits - USD 9,000 (Save 10%)

Go-to-market motion2 records

Distribution channels4 records

Marketing channels8 records

Towards Healthcare product offering

Product offering

Core offering

Towards Healthcare Research & Consulting is a healthcare-focused market research firm that sells syndicated market research reports, custom research and consulting engagements, and subscription-based access to specialized healthcare intelligence platforms covering biotechnology, diagnostics, medical devices, healthcare IT, therapeutic areas, and cell and gene therapy. It also publishes press releases on behalf of clients and offers market databooks, company profiles, segmental analysis, and market share analysis as integrated research deliverables.

Product overview

Towards Healthcare operates as a comprehensive healthcare market research platform offering multiple integrated products and services. The core offering includes the Healthcare Intelligence Platform and Cell & Gene Therapy Intelligence Platform, supplemented by syndicated and custom market research reports. Additional modules include Market Databook, Company Profiles, Segmental Analysis, and Market Share Analysis services. The platform provides subscription-based access to research reports, analytics, and strategic insights across healthcare segments including biotechnology, diagnostics, medical devices, healthcare IT, and therapeutic areas.

Differentiator

Problem solved

Functional benefit

Brands

  • Cell & Gene Therapy Intelligence Platform: Real-time intelligence platform for global cell and gene therapy industry, providing data on market size, patient populations, pipeline programs, and manufacturing facilities.

Products and services

  • Healthcare Intelligence Platform

Quantifiable outcome

  • Serves 1,200+ active clients globally across 50+ countries
  • +2 more outcomes

Companies that use Towards Healthcare

Customer profile

Named customers17 records

Segments6 records

Ideal customer profiles5 records

Towards Healthcare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature4 records

Towards Healthcare partnerships and signals

Strategic signal

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Towards Healthcare competitors and assessment

Company assessment

Direct peers

  • Frost & Sullivan: Long-standing provider of syndicated market research, custom consulting, and Growth Partnership subscriptions across healthcare and other verticals. Directly overlaps with Towards Healthcare's subscription + custom research revenue model.
  • Roots Analysis: Specialized market research provider focused on advanced therapeutics, including cell and gene therapy. Direct competitor to Towards Healthcare's specialized CGT Intelligence Platform and adjacent syndicated offerings.
  • Grand View Research: Syndicated market research publisher with strong healthcare coverage and similar report-based, license-tier pricing. Competes head-to-head for mid-market enterprise healthcare research buyers.
  • GlobalData: Large-scale syndicated and custom research provider with deep healthcare and life sciences coverage. Direct competitor to Towards Healthcare's syndicated intelligence and Company Profiles offerings, but at significantly larger scale.
  • Mordor Intelligence: India-headquartered market research firm selling syndicated reports and consulting across healthcare and other industries. Closely comparable to Towards Healthcare in size, pricing model, and digital self-serve distribution.
  • Coherent Market Insights: Healthcare-focused market research firm with syndicated reports and consulting services. Competes on similar pricing tiers, digital self-serve model, and pharmaceutical/biotech customer base.
  • DelveInsight: Healthcare-focused market research and consulting firm covering pharma, biotech, and emerging therapies. Direct competitor in the same customer base (Roche, AbbVie, Merck, etc.) and overlapping cell & gene therapy and pipeline intelligence.
  • Market Research Future: Syndicated research publisher with broad healthcare, biotech, and medical device coverage. Competes on similar report pricing, digital distribution, and global enterprise buyer targets.

Broad incumbents

  • IQVIA: Global leader in healthcare intelligence, clinical research, and commercial analytics. Competes with Towards Healthcare for enterprise pharma and biotech market intelligence budgets, but with vastly deeper data assets and an integrated services stack.

Emerging players

  • Precedence Research: Affiliated research platform sharing team members with Towards Healthcare; provides syndicated market research across healthcare and other industries. Closely related entity rather than a pure competitor, but shares IP and analyst resources.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Towards Healthcare social profiles

Digital presence

Towards Healthcare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Towards Healthcare leadership team

Management profile

Number of profiles

Profiles8 records

Towards Healthcare funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Towards Healthcare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Towards Healthcare

What does Towards Healthcare do?

Towards Healthcare Research & Consulting is a healthcare-focused market research firm that sells syndicated market research reports, custom research and consulting engagements, and subscription-based access to specialized healthcare intelligence platforms covering biotechnology, diagnostics, medical devices, healthcare IT, therapeutic areas, and cell and gene therapy. It also publishes press releases on behalf of clients and offers market databooks, company profiles, segmental analysis, and market share analysis as integrated research deliverables.

Is Towards Healthcare a public or private company?

Towards Healthcare is a private company. It is classified as unknown and is currently operating.

When was Towards Healthcare founded?

Towards Healthcare was founded in -1. It employs 51 to 100 people.

Where is Towards Healthcare based?

Towards Healthcare is headquartered in Pune, India, in the Asia region.

How does Towards Healthcare make money?

Four revenue lines are on record. Annual Subscription Membership is the primary driver. The others are market Research Reports (One-time Purchase), press Release Services and custom Research and Consulting.

Who are Towards Healthcare's main competitors?

Direct peers on record are Frost & Sullivan, Roots Analysis, Grand View Research, GlobalData, Mordor Intelligence, Coherent Market Insights, DelveInsight and Market Research Future. IQVIA is listed as a broad incumbent. Precedence Research is listed as an emerging player.

Does Towards Healthcare have an API?

No public API is recorded for Towards Healthcare.

What industry is Towards Healthcare in?

Towards Healthcare's product category is Healthcare Market Research & Intelligence. Its primary akta.pro industry code is BPAHALAE, Industry & Sector Research (Syndicated/Custom). Its NAICS code is 54169 and its SIC code is 8742.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
BioSpaceCell and Gene Therapy Enters Its Commercial Reckoning - Towards Healthcare Launches the Intelligence Infrastructure the Industry Now RequiresTowards Healthcare announced the launch of its Cell & Gene Therapy Intelligence Dashboard, a real-time decision-support platform designed to help pharmaceutical and biotechnology companies monitor rapid changes in regulatory approvals, manufacturing capacity, and safety signals. The announcement coincides with a market analysis highlighting significant shifts in the industry, including major M&A activity by AbbVie and Eli Lilly, capacity expansions by CDMOs like Lonza and Fujifilm Diosynth, and heightened regulatory scrutiny following safety events involving Sarepta Therapeutics and Intellia Therapeutics.BioSpaceTrack 1300+ Cell & Gene Therapy Programs, 500+ Manufacturing Facilities, Clinical Trials, Funding Activity and Market Opportunities from a Single PlatformThe article discusses the development of the Cell & Gene Therapy (CGT) industry, emphasizing the importance of an integrated intelligence platform developed by Towards Healthcare. This platform tracks pipeline programs, clinical trials, regulatory trends, investments, and manufacturing, enabling stakeholders to make informed strategic decisions amid a rapidly evolving landscape.GlobeNewswireDigital Therapeutics Set to Surge to Historic Heights by 2036 Across Multiple Segments – Towards Healthcare Research and ConsultingTowards Healthcare Research and Consulting reports that the global digital therapeutics market is projected to grow from USD 12.58 billion in 2026 to USD 114.37 billion by 2035, representing a CAGR of 27.8%. North America currently dominates with a 41% market share, while the Asia-Pacific region is anticipated to experience the fastest growth rate during the forecast period. Key applications include diabetes management and obesity treatment, with significant drivers being regulatory support and increased patient adoption.YahooDigital Health Monitoring Devices Market Size to Reach USD 35.12B by 2035 from USD 7.40B in 2026 (CAGR 18.90%)Towards Healthcare published a market research report estimating the global digital health monitoring devices market at USD 7.40 billion in 2026, projected to reach USD 35.12 billion by 2035 with a CAGR of 18.90%. The report provides comprehensive segmentation analysis across device types, monitoring parameters, technologies, applications, end-users, and regions, identifying wearable devices (42% share in 2025) and remote patient monitoring (34% share) as dominant segments. North America held the largest regional market share at 38% in 2025, while Asia Pacific is projected to grow at the fastest rate during the forecast period.BioSpaceHigh Potency API Market Size to Hit USD 69.13 Billion by 2035 | CAGR 8.4%Towards Healthcare published a market forecast projecting the global high-potency active pharmaceutical ingredients (HPAPI) market to grow from USD 33.45 billion in 2026 to USD 69.13 billion by 2035 at a CAGR of 8.4%. The report identifies North America as the dominant region with a 40% market share, driven by advanced manufacturing capabilities and oncology demand, while Asia Pacific is expected to see the fastest growth. Key industry players such as BASF SE, Pfizer, and AbbVie Inc. are highlighted within this expanding sector focused on cancer treatments and specialized drug delivery systems.Towards HealthcareAAV Gene Therapy Market to Grow at 40.1% CAGR till 2035The global AAV gene therapy market is projected to grow from USD 3.85 billion in 2025 to USD 112.24 billion by 2035, representing a compound annual growth rate of 40.1%, according to market analysis by Towards Healthcare Research & Consulting. North America led the global market with a 54% revenue share in 2025, driven by favorable regulatory policies and advanced R&D infrastructure, while the Asia-Pacific region is expected to grow at the fastest CAGR of 27–29% during the forecast period. Key therapeutic applications driving demand include neurological disorders, which held 39% market share in 2024, and hematologic disorders, with three AAV gene therapies approved by the FDA for hemophilia treatment between 2022–2024.YahooGeneric Pharmaceuticals Contract Manufacturing Market to Reach USD 143.22 Billion by 2035, Driven by Demand for Affordable TherapiesTowards Healthcare published a market study projecting the global generic pharmaceuticals contract manufacturing market will grow from USD 81.24 billion in 2025 to USD 143.22 billion by 2035 at a CAGR of 5.85%. The report highlights key growth drivers such as patent expirations, demand for affordable therapies, and technological advancements, while noting stringent regulations as a primary challenge. Specific industry developments include Piramal Pharma Solutions' $90 million investment in U.S. facilities and Jubilant Biosys' acquisition of an 80% stake in JASMIN.GlobeNewswireMonoclonal Antibody Discovery Platform Market to Reach USD 11.93 Billion by 2035, Expanding at a 12.55% CAGRTowards Healthcare reports that the global monoclonal antibody discovery platform market is projected to grow from USD 4.12 billion in 2026 to USD 11.93 billion by 2035, driven by increased investments and demand for novel therapeutics. The report highlights key regional trends, with North America dominating the market share while Asia-Pacific exhibits the fastest growth, alongside technological shifts toward computational platforms and bispecific antibodies. Recent industry developments include strategic collaborations between major players like Sanofi, InduPro, and Boehringer Ingelheim, as well as new product launches aimed at treating oncology and autoimmune diseases.GlobeNewswireCell and Gene Therapy Market Size to Worth USD 232.22 Billion, Rising at 24% CAGR by 2035Towards Healthcare projects the global cell and gene therapy market will grow from USD 33.5 billion in 2026 to USD 232.22 billion by 2035, driven by rising chronic disease burdens and technological advancements like AI and CRISPR. The report highlights significant regional expansion, with North America leading current revenue while Asia Pacific is expected to see the fastest growth rates.YahooCell and Gene Therapy Market Size to Worth USD 232.22 Billion, Rising at 24% CAGR by 2035A study published by Towards Healthcare projects the global cell and gene therapy market to grow from USD 33.5 billion in 2026 to USD 232.22 billion by 2035, representing a 24% CAGR over the forecast period. Key growth drivers include the rising global burden of chronic, rare, and oncological diseases, advancements in gene-editing technologies such as CRISPR, and the integration of AI and machine learning across R&D and manufacturing. Major biopharmaceutical companies are actively securing investments and advancing clinical programs, with therapies like CAR-T demonstrating strong efficacy in hematologic cancers and gene therapies expanding into neurological, cardiovascular, and autoimmune indications.